STEPHANIE LARRICK: Open Payments
NPI 1588385355 · DEDHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 58 payments from 21 companies in 2025. Trend: 2023 $1,700 · 2024 $1,071 · 2025 $1,425
Food & beverage: $1,425
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 8 | $224 |
| Sumitomo Pharma America, Inc. | 8 | $157 |
| Merck Sharp & Dohme LLC | 5 | $148 |
| Astellas Pharma US Inc | 5 | $137 |
| Antares Pharma, Inc. | 4 | $102 |
| 180 Medical, Inc. | 3 | $87 |
| Ferring Pharmaceuticals Inc. | 4 | $81 |
| ACCORD HEALTHCARE, INC. | 3 | $70 |
| IMMUNITYBIO, INC. | 2 | $55 |
| BIOPROTECT MEDICAL, INC. | 2 | $50 |
Products named: GEMTESA, KEYTRUDA, Veozah, XIAFLEX, AVEED, XYOSTED, ADSTILADRIN, Camcevi.
Industry payments across MA — which companies pay providers there.
